Intuitive Surgical Posts Strong Q1 Beat, Revenue Up 23% on Da Vinci System Growth
ISRG is trading near its 52-week low of $427.836 (5.4% above the low).
Summary
Intuitive Surgical reported first-quarter 2026 results that significantly exceeded analyst expectations, with revenue rising 23% to $2.77 billion against a $2.62 billion consensus, and adjusted earnings per share of $2.50 handily beating the $2.12 estimate. This strong performance continues the positive trend from the company's robust 2025 financial results. The substantial beats were driven by a significant increase in da Vinci system placements, with 431 systems placed compared to 367 a year ago, alongside higher procedure volumes and an expanded installed base. This operational strength and financial outperformance represent a material positive catalyst for the stock. Traders will be watching the company's reaffirmed guidance for worldwide da Vinci procedure growth of 13.5% to 15.5% in 2026 as a key indicator of continued momentum.
At the time of this announcement, ISRG was trading at $450.84 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $160.3B. The 52-week trading range was $427.84 to $603.88. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.